Article

Aging, glaucomatous eyes may differ in rate of axon loss

San Diego-The rate of change in axon loss, not the location of the damage, most likely differentiates an aging eye from a glaucomatous eye, according to recent research, said Claude F. Burgoyne, MD, holder of the Van Buskirk Chair for Ophthalmic Research, Devers Eye Institute, Portland, OR.

San Diego—The rate of change in axon loss, not the location of the damage, most likely differentiates an aging eye from a glaucomatous eye, according to recent research, said Claude F. Burgoyne, MD, holder of the Van Buskirk Chair for Ophthalmic Research, Devers Eye Institute, Portland, OR.

Such a differentiation could help ophthalmologists determine whether axon loss in an eye with glaucoma is due to aging or due to the disease and whether an IOP-lowering intervention might slow the rate of change.

“Whether it’s glaucoma or aging, the rate of change is essential to determine,” however, he said. “There’s a growing movement to do rate-of-change characterization for both structure and visual field.”

A growing body of literature is examining the overlap of disc and field change in patients with glaucoma and “age-matched normal” patients followed over time for progression, he said.

“Increasingly, the [glaucoma-related] data will be overlaid onto age-matched normals over time so that you can estimate the rate of change in your parameters relative to age-matched normals,” Dr. Burgoyne predicted,

When deciding whether to treat IOP in an aged patient with slowly progressing disease, he said, “all of our current parameters will pertain,” including life expectancy, the risks of lowering IOP, and whether an age-related rate of axon loss affects central vision.

“However, if the pathophysiology of aging and glaucoma can be shown to be linked…it’s reasonable to consider that lowering IOP can influence the rate of [progression previously attributed to aging],” Dr. Burgoyne concluded.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
© 2025 MJH Life Sciences

All rights reserved.